{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "authorship_tag": "ABX9TyPCo76p3RoROEtkoydXAH5A",
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/stogaja/clinical-trials/blob/main/clinical_trials.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 5,
      "metadata": {
        "id": "KKiXH-47oP5i"
      },
      "outputs": [],
      "source": [
        "# lets import the libraries we need\n",
        "import pandas as pd\n",
        "import numpy as np\n",
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns\n",
        "from sklearn import svm\n",
        "from sklearn.model_selection import train_test_split\n",
        "from sklearn.ensemble import RandomForestClassifier\n",
        "from sklearn.preprocessing import StandardScaler, LabelEncoder, Normalizer\n",
        "from sklearn.discriminant_analysis import LinearDiscriminantAnalysis as LDA\n",
        "from sklearn.model_selection import train_test_split\n",
        "from sklearn.metrics import r2_score, f1_score, precision_score, recall_score, classification_report, accuracy_score, confusion_matrix, ConfusionMatrixDisplay\n",
        "from sklearn.neighbors import KNeighborsClassifier\n",
        "from sklearn.naive_bayes import GaussianNB, MultinomialNB, BernoulliNB, ComplementNB, CategoricalNB\n",
        "from sklearn.model_selection import GridSearchCV, RandomizedSearchCV\n",
        "from sklearn.tree import export_graphviz\n",
        "from six import StringIO\n",
        "from IPython.display import Image\n",
        "import pydotplus\n",
        "import os\n",
        "\n",
        "# filter to ignore warnings\n",
        "import warnings\n",
        "warnings.filterwarnings('ignore')\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# lets create a function to read the data\n",
        "def read_data(data):\n",
        "   df = pd.read_csv(data)\n",
        "   return df"
      ],
      "metadata": {
        "id": "OphEPi3lrQKY"
      },
      "execution_count": 6,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# lets define a list of the csv file names\n",
        "file_names = [\n",
        "   'Cancer-studies.csv',\n",
        "   'Covid 19-studies.csv',\n",
        "   'Heart.csv',\n",
        "   'HIV-studies.csv',\n",
        "   'Malaria-studies.csv',\n",
        "   'Pneumonia-studies.csv'\n",
        "]\n",
        "\n",
        "# let's create an empty dictionary to store the dataframes\n",
        "data_frames = {}\n",
        "\n",
        "# lets loop through the file names and read the data into dataframes\n",
        "for file_name in file_names:\n",
        "   name = file_name.split('.')[0] # this extracts name from file name\n",
        "   data_frames[name] = read_data(file_name)\n"
      ],
      "metadata": {
        "id": "W8vpaCnxrRJp"
      },
      "execution_count": 7,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# lets iterate through the dictionary and print the name of each dataframe\n",
        "for name, df in data_frames.items():\n",
        "    print(f'{name}: rows = {df.shape[0]} and columns = {df.shape[1]}')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "SFxpCz-frSZ_",
        "outputId": "e05f54fb-1fe1-462e-ea2d-114679203a30"
      },
      "execution_count": 8,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Cancer-studies: rows = 100262 and columns = 30\n",
            "Covid 19-studies: rows = 9342 and columns = 30\n",
            "Heart: rows = 32176 and columns = 30\n",
            "HIV-studies: rows = 9113 and columns = 30\n",
            "Malaria-studies: rows = 1330 and columns = 30\n",
            "Pneumonia-studies: rows = 9640 and columns = 30\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# lets preview the top entries of the datasets using a for loop\n",
        "for name, df in data_frames.items():\n",
        "   print(f\"Top view of {name}:\")\n",
        "   print(df.head(4))\n",
        "   print(\"=\"*30) # separator for clarity"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "4x9x6U1KrS4I",
        "outputId": "77b9d8d2-6953-46c5-f3eb-adafb6ad8a0a"
      },
      "execution_count": 9,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Top view of Cancer-studies:\n",
            "    NCT Number                                        Study Title  \\\n",
            "0  NCT02426125  A Study of Ramucirumab (LY3009806) Plus Doceta...   \n",
            "1  NCT04910425  PSMA-Targeted 18F-DCFPyL PET/MRI for the Detec...   \n",
            "2  NCT04116125  Omitting Biopsy of SEntinel Lymph Node With Ra...   \n",
            "3  NCT03566225  Pioglitazone Versus Metformin as First Treatme...   \n",
            "\n",
            "                                      Study URL Acronym        Study Status  \\\n",
            "0  https://clinicaltrials.gov/study/NCT02426125   RANGE           COMPLETED   \n",
            "1  https://clinicaltrials.gov/study/NCT04910425     NaN  NOT_YET_RECRUITING   \n",
            "2  https://clinicaltrials.gov/study/NCT04116125  OBSERB  NOT_YET_RECRUITING   \n",
            "3  https://clinicaltrials.gov/study/NCT03566225     NaN           COMPLETED   \n",
            "\n",
            "                                       Brief Summary Study Results  \\\n",
            "0  The main purpose of this study is to evaluate ...           YES   \n",
            "1  This phase II trial studies how well 18F-DCFPy...            NO   \n",
            "2  The OBSERB study is a multi-center, non-blinde...            NO   \n",
            "3  Participants with PCOS will be divided into tw...            NO   \n",
            "\n",
            "                                    Conditions  \\\n",
            "0                         Urothelial Carcinoma   \n",
            "1                           Prostate Carcinoma   \n",
            "2  Breast Neoplasm Female|Lymphatic Metastasis   \n",
            "3                                 Pioglitazone   \n",
            "\n",
            "                                       Interventions  \\\n",
            "0    DRUG: Ramucirumab|DRUG: Docetaxel|DRUG: Placebo   \n",
            "1  DRUG: Fluorine F 18 DCFPyL|DRUG: Gadobenate Di...   \n",
            "2                            PROCEDURE: Radiotherapy   \n",
            "3  DRUG: Pioglitazone|DRUG: Metformin|DRUG: Clomi...   \n",
            "\n",
            "                            Primary Outcome Measures  ...  \\\n",
            "0  Progression Free Survival (PFS), PFS defined a...  ...   \n",
            "1  18-F-DCFPyL positron emission tomography (PET)...  ...   \n",
            "2  Disease-free survival, Disease free survival i...  ...   \n",
            "3  Clinical pregnancy rate, Pregnancy rate diagno...  ...   \n",
            "\n",
            "                                        Study Design  \\\n",
            "0  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
            "1  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
            "2  Allocation: RANDOMIZED|Intervention Model: SIN...   \n",
            "3  Allocation: RANDOMIZED|Intervention Model: SIN...   \n",
            "\n",
            "                                           Other IDs  Start Date  \\\n",
            "0                   15679|I4T-MC-JVDC|2014-003655-66  2015-07-13   \n",
            "1  NU 19U05|NCI-2021-05593|STU00212326|NU 19U05|P...  2023-06-17   \n",
            "2                                        2019-09-023  2020-07-01   \n",
            "3                                          AinShamaU  2018-01-30   \n",
            "\n",
            "  Primary Completion Date Completion Date First Posted Results First Posted  \\\n",
            "0              2017-04-21      2022-07-26   2015-04-24           2019-01-25   \n",
            "1              2026-06-17         2028-07   2021-06-02                  NaN   \n",
            "2              2023-06-30      2025-06-30   2019-10-04                  NaN   \n",
            "3              2021-02-28      2021-03-30   2018-06-25                  NaN   \n",
            "\n",
            "   Last Update Posted                                          Locations  \\\n",
            "0          2023-08-21  Highlands Oncology Group, Fayetteville, Arkans...   \n",
            "1          2022-08-03  Northwestern University, Chicago, Illinois, 60...   \n",
            "2          2019-10-04                                                NaN   \n",
            "3          2021-06-02                Ain Shams Univerisity, Cairo, Egypt   \n",
            "\n",
            "                            Study Documents  \n",
            "0  Study Protocol|Statistical Analysis Plan  \n",
            "1                                       NaN  \n",
            "2                                       NaN  \n",
            "3                                       NaN  \n",
            "\n",
            "[4 rows x 30 columns]\n",
            "==============================\n",
            "Top view of Covid 19-studies:\n",
            "    NCT Number                                        Study Title  \\\n",
            "0  NCT04614025  Open-label Multicenter Study to Evaluate the E...   \n",
            "1  NCT04646525  The Relationship Between Covid-19 Infection in...   \n",
            "2  NCT04333225  Hydroxychloroquine in the Prevention of COVID-...   \n",
            "3  NCT04996225  Effect of Aerobics and Balancing Exercises on ...   \n",
            "\n",
            "                                      Study URL Acronym  \\\n",
            "0  https://clinicaltrials.gov/study/NCT04614025     NaN   \n",
            "1  https://clinicaltrials.gov/study/NCT04646525     NaN   \n",
            "2  https://clinicaltrials.gov/study/NCT04333225     NaN   \n",
            "3  https://clinicaltrials.gov/study/NCT04996225     NaN   \n",
            "\n",
            "            Study Status                                      Brief Summary  \\\n",
            "0  ACTIVE_NOT_RECRUITING  This clinical trial will examine if a new trea...   \n",
            "1                UNKNOWN  We aimed to find out whether the tonsils and n...   \n",
            "2              COMPLETED  In order to assess the efficacy of hydroxychlo...   \n",
            "3              COMPLETED  The recently emerged coronavirus named Severe ...   \n",
            "\n",
            "  Study Results                                         Conditions  \\\n",
            "0            NO                                         COVID|ARDS   \n",
            "1            NO  Covid19|Immune Deficiency|Tonsillitis|Tonsil H...   \n",
            "2           YES                                           COVID-19   \n",
            "3            NO                             Corona Virus Infection   \n",
            "\n",
            "                                  Interventions  \\\n",
            "0                           BIOLOGICAL: PLX-PAD   \n",
            "1         DIAGNOSTIC_TEST: Physical examination   \n",
            "2                      DRUG: Hydroxychloroquine   \n",
            "3  OTHER: Aerobics exercises, Balance exercises   \n",
            "\n",
            "                            Primary Outcome Measures  ...  \\\n",
            "0            Number of ventilator-free days, 28 days  ...   \n",
            "1  The primary outcome of our study was the evalu...  ...   \n",
            "2  Number of Participants Infected With COVID-19 ...  ...   \n",
            "3  SPSS for Windows, version 22 (SPSS Inc., Chica...  ...   \n",
            "\n",
            "                                        Study Design       Other IDs  \\\n",
            "0  Allocation: RANDOMIZED|Intervention Model: PAR...      PLX-COV-03   \n",
            "1          Observational Model: |Time Perspective: p        2020/480   \n",
            "2  Allocation: NON_RANDOMIZED|Intervention Model:...         020-132   \n",
            "3  Allocation: RANDOMIZED|Intervention Model: PAR...  A,B E COVID 19   \n",
            "\n",
            "   Start Date Primary Completion Date Completion Date First Posted  \\\n",
            "0  2020-10-19              2021-08-04         2023-01   2020-11-03   \n",
            "1  2020-10-01              2021-02-01      2021-02-01   2020-11-30   \n",
            "2  2020-04-03              2020-06-30      2020-06-30   2020-04-03   \n",
            "3  2021-08-01              2022-10-25      2023-02-10   2021-08-09   \n",
            "\n",
            "  Results First Posted  Last Update Posted  \\\n",
            "0                  NaN          2022-12-21   \n",
            "1                  NaN          2020-11-30   \n",
            "2           2021-08-02          2021-08-20   \n",
            "3                  NaN          2023-02-22   \n",
            "\n",
            "                                           Locations  \\\n",
            "0  Charite Campus Virchow, Berlin, 10117, Germany...   \n",
            "1  Selcuk University, Konya, Selcuklu, 42100, Turkey   \n",
            "2  Baylor University Medical Center, Dallas, Texa...   \n",
            "3                   Ahmed.Assem, Sohag, 82951, Egypt   \n",
            "\n",
            "                            Study Documents  \n",
            "0                                       NaN  \n",
            "1                                       NaN  \n",
            "2  Study Protocol|Statistical Analysis Plan  \n",
            "3                                       NaN  \n",
            "\n",
            "[4 rows x 30 columns]\n",
            "==============================\n",
            "Top view of Heart:\n",
            "    NCT Number                                        Study Title  \\\n",
            "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
            "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
            "2  NCT03176225  Evaluate Safety and Effectiveness of XenoSure ...   \n",
            "3  NCT00199225  Evaluation of Possible Effects on the QT/ QTc ...   \n",
            "\n",
            "                                      Study URL Acronym  \\\n",
            "0  https://clinicaltrials.gov/study/NCT00291525  PROACT   \n",
            "1  https://clinicaltrials.gov/study/NCT03419325     NaN   \n",
            "2  https://clinicaltrials.gov/study/NCT03176225     NaN   \n",
            "3  https://clinicaltrials.gov/study/NCT00199225     NaN   \n",
            "\n",
            "            Study Status                                      Brief Summary  \\\n",
            "0  ACTIVE_NOT_RECRUITING  Various patient groups with the On-X Valve can...   \n",
            "1  ACTIVE_NOT_RECRUITING  Clopidogrel is a prescription medicine used to...   \n",
            "2             RECRUITING  The purpose of this clinical trial is to colle...   \n",
            "3              COMPLETED  This phase I trial will evaluate the effects o...   \n",
            "\n",
            "  Study Results                                         Conditions  \\\n",
            "0            NO                                Heart Valve Disease   \n",
            "1            NO  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
            "2            NO                                     Heart Diseases   \n",
            "3            NO           Human Experimentation (Human Volunteers)   \n",
            "\n",
            "                                       Interventions  \\\n",
            "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
            "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
            "2  PROCEDURE: Open heart surgery to address the h...   \n",
            "3  DRUG: Rupatadine|DRUG: moxifloxacin|PROCEDURE:...   \n",
            "\n",
            "                            Primary Outcome Measures  ...  \\\n",
            "0  Thromboembolism, Rate of thromboembolism evalu...  ...   \n",
            "1  Major adverse cardiovascular events (MACE) red...  ...   \n",
            "2  Leakage rate at 6 month post-procedure measure...  ...   \n",
            "3  To assess whether administration of a repeated...  ...   \n",
            "\n",
            "                                        Study Design  \\\n",
            "0  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
            "1  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
            "2  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
            "3  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
            "\n",
            "                  Other IDs  Start Date Primary Completion Date  \\\n",
            "0           2005-01|G050208  2006-06-06              2022-12-31   \n",
            "1  A4070417|2U54MD007600-31  2020-09-01              2023-04-30   \n",
            "2                  P15077-1  2017-08-15              2025-11-15   \n",
            "3             IC012RUP/1/04     2005-02                     NaN   \n",
            "\n",
            "  Completion Date First Posted Results First Posted  Last Update Posted  \\\n",
            "0      2022-12-31   2006-02-14                  NaN          2022-09-14   \n",
            "1      2023-12-30   2018-02-01                  NaN          2023-05-30   \n",
            "2      2026-02-15   2017-06-05                  NaN          2023-03-10   \n",
            "3         2005-07   2005-09-20                  NaN          2005-12-15   \n",
            "\n",
            "                                           Locations Study Documents  \n",
            "0  Tucson Medical Center, Tucson, Arizona, 85718,...             NaN  \n",
            "1  University Hospital at Carolina, Carolina, 009...             NaN  \n",
            "2  Chinese PLA General Hospital, Beijing, Beijing...             NaN  \n",
            "3  Centre de InvestigaciÃ³ de Medicaments-Intitut ...             NaN  \n",
            "\n",
            "[4 rows x 30 columns]\n",
            "==============================\n",
            "Top view of HIV-studies:\n",
            "    NCT Number                                        Study Title  \\\n",
            "0  NCT00914225  Effect of Bednets and a Water Purification Dev...   \n",
            "1  NCT02167425  Study of Integrating Antiretroviral Therapy Wi...   \n",
            "2  NCT01423825  Evaluating the Safety and Immune Response to a...   \n",
            "3  NCT02098525  Clinical Outcomes of Cryptococcal Meningitis A...   \n",
            "\n",
            "                                      Study URL Acronym Study Status  \\\n",
            "0  https://clinicaltrials.gov/study/NCT00914225     ITN    COMPLETED   \n",
            "1  https://clinicaltrials.gov/study/NCT02167425    IMAT      UNKNOWN   \n",
            "2  https://clinicaltrials.gov/study/NCT01423825     NaN    COMPLETED   \n",
            "3  https://clinicaltrials.gov/study/NCT02098525     NaN    COMPLETED   \n",
            "\n",
            "                                       Brief Summary Study Results  \\\n",
            "0  In many areas of the world most severely affec...            NO   \n",
            "1  To improve ART initiation among people who inj...            NO   \n",
            "2  This is an extension of the HVTN 073/SAAVI 102...            NO   \n",
            "3  Cryptococcal meningitis is one of the most com...            NO   \n",
            "\n",
            "                                          Conditions  \\\n",
            "0  HIV Infections|Human Immunodeficiency Virus|Ma...   \n",
            "1                              HIV|Opioid Dependence   \n",
            "2                                     HIV Infections   \n",
            "3                   Cryptococcal Meningitis|HIV/AIDS   \n",
            "\n",
            "                                       Interventions  \\\n",
            "0              OTHER: Bednets and Water Purification   \n",
            "1                                        OTHER: IMAT   \n",
            "2  BIOLOGICAL: Sub C gp140 Vaccine|BIOLOGICAL: MF...   \n",
            "3                                                NaN   \n",
            "\n",
            "                            Primary Outcome Measures  ...  \\\n",
            "0  To determine the effect of LLIN and a simple m...  ...   \n",
            "1  Time to CD4 Screening, Number of days between ...  ...   \n",
            "2  Safety data, including signs and symptoms of l...  ...   \n",
            "3  Long-term survival rate of CM, To describe lon...  ...   \n",
            "\n",
            "                                        Study Design  \\\n",
            "0          Observational Model: |Time Perspective: p   \n",
            "1          Observational Model: |Time Perspective: p   \n",
            "2  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
            "3          Observational Model: |Time Perspective: p   \n",
            "\n",
            "                   Other IDs Start Date Primary Completion Date  \\\n",
            "0           35464-B|SSC#1554    2009-09                 2011-12   \n",
            "1        IMAT-01|R34DA037787    2015-02                 2017-03   \n",
            "2  HVTN 073E/SAAVI 102|11824    2011-08                 2013-07   \n",
            "3                   HIVCM-01    2013-11                 2013-12   \n",
            "\n",
            "  Completion Date First Posted Results First Posted  Last Update Posted  \\\n",
            "0         2011-12   2009-06-04                  NaN          2015-05-29   \n",
            "1         2017-03   2014-06-19                  NaN          2015-11-23   \n",
            "2         2013-07   2011-08-26                  NaN          2021-10-14   \n",
            "3             NaN   2014-03-28                  NaN          2014-03-28   \n",
            "\n",
            "                                           Locations Study Documents  \n",
            "0  Kisii Provincial Hospital, Kisii, Kenya|Kisumu...             NaN  \n",
            "1                                                NaN             NaN  \n",
            "2  Brigham and Women's Hospital Vaccine CRS (BWH ...             NaN  \n",
            "3  Division of Infectious Diseases, Department of...             NaN  \n",
            "\n",
            "[4 rows x 30 columns]\n",
            "==============================\n",
            "Top view of Malaria-studies:\n",
            "    NCT Number                                        Study Title  \\\n",
            "0  NCT01976325         Evaluating the Ottawa Malaria Decision Aid   \n",
            "1  NCT00914225  Effect of Bednets and a Water Purification Dev...   \n",
            "2  NCT05605925  Ivermectin-artemisinin Combination Therapy for...   \n",
            "3  NCT01464125  Fosmidomycin and Azithromycin for Acute Uncomp...   \n",
            "\n",
            "                                      Study URL Acronym Study Status  \\\n",
            "0  https://clinicaltrials.gov/study/NCT01976325    OMDA      UNKNOWN   \n",
            "1  https://clinicaltrials.gov/study/NCT00914225     ITN    COMPLETED   \n",
            "2  https://clinicaltrials.gov/study/NCT05605925   IVIME   RECRUITING   \n",
            "3  https://clinicaltrials.gov/study/NCT01464125   JP011      UNKNOWN   \n",
            "\n",
            "                                       Brief Summary Study Results  \\\n",
            "0  BRIEF SUMMARY\\n\\nCanadians often visit areas w...            NO   \n",
            "1  In many areas of the world most severely affec...            NO   \n",
            "2  Malaria remains a leading cause of morbidity a...            NO   \n",
            "3  The aim of this study is to evaluate the role ...            NO   \n",
            "\n",
            "                                          Conditions  \\\n",
            "0                                            Malaria   \n",
            "1  HIV Infections|Human Immunodeficiency Virus|Ma...   \n",
            "2                                            Malaria   \n",
            "3                                            Malaria   \n",
            "\n",
            "                                    Interventions  \\\n",
            "0              OTHER: Ottawa Malaria Decision Aid   \n",
            "1           OTHER: Bednets and Water Purification   \n",
            "2  DRUG: Artemether/lumefantrine|DRUG: Ivermectin   \n",
            "3           DRUG: Fosmidomycin|DRUG: Azithromycin   \n",
            "\n",
            "                            Primary Outcome Measures  ...  \\\n",
            "0  Travellers' Knowledge Score, The traveller's k...  ...   \n",
            "1  To determine the effect of LLIN and a simple m...  ...   \n",
            "2  Malaria transmission rates in a household, Mal...  ...   \n",
            "3  day 28 cure rate of >95%, Efficacy of fosmidom...  ...   \n",
            "\n",
            "                                        Study Design           Other IDs  \\\n",
            "0  Allocation: RANDOMIZED|Intervention Model: PAR...         2010462-01H   \n",
            "1          Observational Model: |Time Perspective: p    35464-B|SSC#1554   \n",
            "2  Allocation: RANDOMIZED|Intervention Model: PAR...  MAKSHSREC-2021-237   \n",
            "3  Allocation: NON_RANDOMIZED|Intervention Model:...               JP011   \n",
            "\n",
            "   Start Date Primary Completion Date Completion Date First Posted  \\\n",
            "0     2014-01                 2015-11         2015-11   2013-11-05   \n",
            "1     2009-09                 2011-12         2011-12   2009-06-04   \n",
            "2  2022-08-04              2022-12-31      2022-12-31   2022-11-04   \n",
            "3     2008-11                 2009-10         2011-12   2011-11-03   \n",
            "\n",
            "  Results First Posted  Last Update Posted  \\\n",
            "0                  NaN          2015-04-16   \n",
            "1                  NaN          2015-05-29   \n",
            "2                  NaN          2022-11-04   \n",
            "3                  NaN          2011-11-03   \n",
            "\n",
            "                                           Locations Study Documents  \n",
            "0  National Capital Region Occupational Health Cl...             NaN  \n",
            "1  Kisii Provincial Hospital, Kisii, Kenya|Kisumu...             NaN  \n",
            "2           ST. Paul's Health Center, Kasese, Uganda             NaN  \n",
            "3       Mahidol University, Bangkok, 10400, Thailand             NaN  \n",
            "\n",
            "[4 rows x 30 columns]\n",
            "==============================\n",
            "Top view of Pneumonia-studies:\n",
            "    NCT Number                                        Study Title  \\\n",
            "0  NCT02708225  The Influence of Medical Clowns on the Perform...   \n",
            "1  NCT03962725  Avoiding Neuromuscular Blockers to Reduce Comp...   \n",
            "2  NCT04646525  The Relationship Between Covid-19 Infection in...   \n",
            "3  NCT04333225  Hydroxychloroquine in the Prevention of COVID-...   \n",
            "\n",
            "                                      Study URL Acronym Study Status  \\\n",
            "0  https://clinicaltrials.gov/study/NCT02708225  clowns      UNKNOWN   \n",
            "1  https://clinicaltrials.gov/study/NCT03962725     NaN   TERMINATED   \n",
            "2  https://clinicaltrials.gov/study/NCT04646525     NaN      UNKNOWN   \n",
            "3  https://clinicaltrials.gov/study/NCT04333225     NaN    COMPLETED   \n",
            "\n",
            "                                       Brief Summary Study Results  \\\n",
            "0  Medical clowns are known to assist in relaxing...            NO   \n",
            "1  The goal of this study to evaluate whether eli...            NO   \n",
            "2  We aimed to find out whether the tonsils and n...            NO   \n",
            "3  In order to assess the efficacy of hydroxychlo...           YES   \n",
            "\n",
            "                                          Conditions  \\\n",
            "0                                   Asthma|Pneumonia   \n",
            "1  Respiratory Failure|Respiratory Infection|Aspi...   \n",
            "2  Covid19|Immune Deficiency|Tonsillitis|Tonsil H...   \n",
            "3                                           COVID-19   \n",
            "\n",
            "                                       Interventions  \\\n",
            "0                          BEHAVIORAL: medical clown   \n",
            "1  DRUG: Neuromuscular Blocking Agents|DRUG: Anes...   \n",
            "2              DIAGNOSTIC_TEST: Physical examination   \n",
            "3                           DRUG: Hydroxychloroquine   \n",
            "\n",
            "                            Primary Outcome Measures  ...  \\\n",
            "0  length of experium (seconds), length of experi...  ...   \n",
            "1  Number of participants who either had postoper...  ...   \n",
            "2  The primary outcome of our study was the evalu...  ...   \n",
            "3  Number of Participants Infected With COVID-19 ...  ...   \n",
            "\n",
            "                                        Study Design    Other IDs  Start Date  \\\n",
            "0  Allocation: RANDOMIZED|Intervention Model: PAR...      0026-15     2016-03   \n",
            "1  Allocation: RANDOMIZED|Intervention Model: PAR...  2019P000260  2019-08-07   \n",
            "2          Observational Model: |Time Perspective: p     2020/480  2020-10-01   \n",
            "3  Allocation: NON_RANDOMIZED|Intervention Model:...      020-132  2020-04-03   \n",
            "\n",
            "  Primary Completion Date Completion Date First Posted Results First Posted  \\\n",
            "0                 2016-10         2017-10   2016-03-15                  NaN   \n",
            "1              2022-12-19      2022-12-19   2019-05-24                  NaN   \n",
            "2              2021-02-01      2021-02-01   2020-11-30                  NaN   \n",
            "3              2020-06-30      2020-06-30   2020-04-03           2021-08-02   \n",
            "\n",
            "   Last Update Posted                                          Locations  \\\n",
            "0          2016-03-15                                                NaN   \n",
            "1          2023-02-02  Massachusetts General Hospital, Boston, Massac...   \n",
            "2          2020-11-30  Selcuk University, Konya, Selcuklu, 42100, Turkey   \n",
            "3          2021-08-20  Baylor University Medical Center, Dallas, Texa...   \n",
            "\n",
            "                            Study Documents  \n",
            "0                                       NaN  \n",
            "1                                       NaN  \n",
            "2                                       NaN  \n",
            "3  Study Protocol|Statistical Analysis Plan  \n",
            "\n",
            "[4 rows x 30 columns]\n",
            "==============================\n"
          ]
        }
      ]
    }
  ]
}